Research progress on surgical and translational treatment of metastatic gastric cancer to the liver at different times

doi:10.3877/cma.j.issn.1674-3946.2026.01.022

Abstract

Abstract:

Gastric cancer metachronous liver metastasis (MLM) progresses relatively slowly, but the prognosis remains poor. In recent years, the application of surgical procedures, especially laparoscopic surgery and robot-assisted surgery, has significantly improved surgical accuracy and enhanced the quality of life for patients. Combined with the conversion treatment strategy, the survival period and disease-free survival period of patients have been further prolonged. This article reviews the progress in surgical and conversion treatment for gastric cancer MLM, discusses the current surgical methods, conversion treatment strategies, and their impact on patient prognosis, providing a basis and reference for clinical treatment decisions.

Key words: Stomach Neoplasms, Metachronous Liver Metastasis, Surgical Therapy, Research Progress

Tongmei Wu, Chunyan Yang. Research progress on surgical and translational treatment of metastatic gastric cancer to the liver at different times[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(01): 78-82.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2026.01.022

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2026/V20/I01/78

Figures/Tables 1

References 64

[1]	He F, Wang S, Zheng R, et al. Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050[J]. Lancet Reg Health West Pac, 2024, 44: 101003.
[2]	彭浩欣, 王雅坤, 陈杨, 等. 2024年度胃癌治疗现状与问题[J/CD]. 肿瘤综合治疗电子杂志, 2025, 11(02): 1-14.
[3]	王晨旭, 魏洁淼, 宋晓晗, 等. 晚期胃癌广泛肝转移转化治疗后R0切除一例[J]. 肝胆胰外科杂志, 2023, 35(11): 685-687.
[4]	赵亚子, 翟建, 赵田英, 等. 术前腹部脂肪含量对胃癌根治术后远处转移的预测价值[J]. 放射学实践, 2023(08): 1033-1038.
[5]	韩颢. 胃癌的远处转移模式——一项基于人口的回顾性研究[D]. 江苏: 南京医科大学, 2023.
[6]	Wang C, Zhang Y, Zhang Y, et al. A bibliometric analysis of gastric cancer liver metastases: advances in mechanisms of occurrence and treatment options [J]. Int J Surg, 2024, 110(4): 2288-2299.
[7]	Yu P, Zhang Y, Ye Z, et al. Treatment of Synchronous Liver Metastases from Gastric Cancer: A Single-Center Study [J]. Cancer Manag Res, 2020, 12: 7905-7911.
[8]	Furukawa S, Kobayashi T, Shiono S, et al. Metachronous Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer Successfully Treated with Capecitabine/Oxaliplatin Combination Chemotherapy [J]. Case Rep Surg, 2022, 2022: 2700394.
[9]	王金榜, 冯伟宇, 徐冬利, 等. 免疫治疗联合化疗在寡转移胃癌手术患者中的治疗效果及对预后的影响[J]. 癌症进展, 2025, 23(09): 1016-1021, 1037.
[10]	蒋子健, 薛侃, 陕飞, 等. 胃癌肝转移患者的治疗方式和预后影响因素分析[J]. 中华消化外科杂志, 2024, 23(12): 1511-1517.
[11]	Yasufuku I, Tsuchiya H, Fujibayashi S, et al. Oligometastasis of Gastric Cancer: A Review [J]. Cancers (Basel), 2024, 16(3): 673.
[12]	Hara K, Cho H, Onodera A, et al. Long-term treatment outcomes in gastric cancer with oligometastasis[J]. Ann Gastroenterol Surg, 2023, 8(01): 60-70.
[13]	卢顺利, 李洪涛, 李正凯, 等. 血清甲胎蛋白阳性胃癌术后肝转移的危险因素分析[J]. 中国现代普通外科进展, 2024, 27(09): 742-744.
[14]	黄可婷, 金多晨, 党旖旎, 等. 内镜切除术后异时性胃癌的研究进展[J]. 中华消化内镜杂志, 2022, 39(01): 78-81.
[15]	王兴国, 张亮刚, 杨中民. 胃癌异时性肝转移影响因素及不同治疗方式的效果和预后分析[J]. 中国现代普通外科进展, 2021, 24(02): 99-103.
[16]	王猛, 姜玉娟, 周思成, 等. 68例结直肠癌异时性肝转移患者术后预后影响因素分析[J]. 肿瘤学杂志, 2022, 28(06): 498-503.
[17]	杨彬, 李明霞, 刘姝兰, 等. 转移性胃癌的多层螺旋CT诊断价值[J]. 实用放射学杂志, 2022, 38(02): 259-262.
[18]	De Vuysere S, Vandecaveye V, De Bruecker Y, et al. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study [J]. BMC Med Imaging, 2021, 21(1): 18.
[19]	Yin H, Luo R, Lv J, et al. Relationship between [18F]FDG PET/CT findings and claudin 18. 2 expression in metastatic gastric cancer [J]. Eur Radiol, 2025, 35(6): 3442-3449.
[20]	Gakuhara A, Fukuda S, Tsujimoto T, et al. AFP and PIVKA-Ⅱ Producing Gastric Cancer with Metachronous Liver Metastasis after Gastrectomy-A Case Report [J]. Gan To Kagaku Ryoho, 2020, 47(13): 2156-2158.
[21]	中国抗癌协会胃癌专业委员会, 中国医师协会外科医师分会上消化道外科医师专家工作组, 中国老年保健协会消化系统疾病诊疗分会, 等. 胃癌肝转移诊断与综合治疗中国专家共识(2024版)[J]. 中国实用外科杂志, 2024, 44(05): 481-489.
[22]	Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) [J]. Gastric Cancer, 2023, 26(1): 1-25.
[23]	Shitara K, Fleitas T, Kawakami H, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer [J]. ESMO Open, 2024, 9(2): 102226.
[24]	Ajani JA, D'Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2. 2022, NCCN Clinical Practice Guidelines in Oncology [J]. J Natl Compr Canc Netw, 2022, 20(2): 167-192.
[25]	蓝煜, 王风华. 2024晚期胃癌诊疗指南更新对比与梳理: CSCO、NCCN和ESMO [J]. 中国癌症杂志, 2025, 35(02): 219-227.
[26]	高云鹤, 郗洪庆, 商亮, 等. 基于真实世界数据的胃癌肝转移全国多中心回顾性队列研究(RECORD研究)年度报告[J]. 中国实用外科杂志, 2024, 44(01): 89-97.
[27]	巨家华. 胃癌异时性肝转移的危险因素与预后分析及相关预测模型的构建[D]. 甘肃: 兰州大学, 2024.
[28]	李力, 高云鹤, 商亮, 等. 初始可切除型胃癌肝转移不同治疗方式预后情况及其影响因素分析的全国多中心临床研究[J]. 中华消化外科杂志, 2024, 23(01): 114-124.
[29]	韦青, 袁幸, 徐琦, 等. Ⅳ期胃癌/食管胃结合部癌肝转移患者临床病理特征及其预后影响因素——一项基于SEER数据库的回顾性研究[J/CD]. 肿瘤综合治疗电子杂志, 2020, 6(02): 113-117.
[30]	孙志伟, 贾军, 杜丰, 等. 不可手术切除的局部进展期或转移性胃癌患者一线化疗前血液肿瘤标志物在预后评估中的价值[J]. 中国普通外科杂志, 2020, 28(08): 1023-1030.
[31]	中国研究型医院学会肝胆胰外科专业委员会, 《中华消化外科杂志》编辑委员会. 腹腔镜解剖性肝切除手术操作流程及技术标准中国专家共识（2023版）[J]. 中华消化外科杂志, 2023, 22(07): 810-823.
[32]	雷彩宁, 李子汉, 李小飞, 等. 解剖性切除与非解剖性切除治疗肝细胞癌患者疗效的Meta分析[J]. 中国普通外科杂志, 2021, 30(02): 195-210.
[33]	Marte G, Tufo A, Steccanella F, et al. Efficacy of Surgery for the Treatment of Gastric Cancer Liver Metastases: A Systematic Review of the Literature and Meta-Analysis of Prognostic Factors [J]. J Clin Med, 2021, 10(5): 1141.
[34]	Aurello P, Minervini A, Pace M, et al. The Role of Surgery in the Treatment of Metachronous Liver Metastasis from Gastric Cancer: A Systematic Review [J]. Anticancer Res, 2022, 42(1): 25-33.
[35]	Yazawa T, Hori T, Yamamoto H, et al. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience [J]. World J Gastrointest Pharmacol Ther, 2020, 11(5): 110-122.
[36]	Takahashi K, Terashima M, Notsu A, et al. Surgical treatment for liver metastasis from gastric cancer: A systematic review and meta-analysis of long-term outcomes and prognostic factors [J]. Eur J Surg Oncol, 2024, 50(10): 108582.
[37]	宋纯, 杜涛. 中国腹腔镜转移性肝癌手术20年术式变迁与发展[J/CD]. 中华普外科手术学杂志(电子版), 2021, 15(04): 359-362.
[38]	Takayama H, Kobayashi S, Gotoh K, et al. Laparoscopic Liver Resection for Small, Solitary, Peripheral-Type Intrahepatic Cholangiocarcinoma, Based on Preoperative Prediction of Lymph Node Metastasis [J]. J Laparoendosc Adv Surg Tech A, 2025, 35(8): 640-651.
[39]	《中华消化外科杂志》编辑委员会. 腹腔镜肝切除手术入路中国专家共识（2023版）[J]. 中华消化外科杂志, 2024, 23(01): 37-48.
[40]	吴磊, 王建, 陈龙, 等. 腹腔镜下胃癌D2根治术联合射频消融应用于胃癌肝转移的临床疗效[J]. 中国内镜杂志, 2021, 27(12): 61-66.
[41]	王晓娜, 付蔚华, 赵永捷, 等. 天津市胃癌发病及治疗分析（附3 122例报告）[J]. 中华消化外科杂志, 2023, 22(10): 1205-1211.
[42]	薛锦慧, 房静远. 早期胃癌内镜治疗术后发生异时性胃癌的影响因素[J]. 中华消化内镜杂志, 2020, 37(03): 221-224.
[43]	中国研究型医院学会肝胆胰外科专业委员会. 腹腔镜肝切除术治疗肝细胞癌中国专家共识(2020版) [J]. 中华消化外科杂志, 2020, 19(11): 1119-1134.
[44]	张炜. 胃ESD术中出血的危险因素分析及Logistic回归模型建立[J]. 中南医学科学杂志, 2023, 51(01): 77-79.
[45]	梁霄, 沈泽锋, 凡豫新, 等. 5G超远程机器人辅助肝切除术的临床实践初探[J]. 中华外科杂志, 2025, 63(06): 508-514.
[46]	Loureiro P, Barbosa JP, Vale JF, et al. Laparoscopic Versus Robotic Gastric Cancer Surgery: Short-Term Outcomes-Systematic Review and Meta-Analysis of 25, 521 Patients [J]. J Laparoendosc Adv Surg Tech A, 2023, 33(8): 782-800.
[47]	鲁首男, 孟展志, 麻勇. 机器人辅助腹腔镜下肝部分切除术在肝癌治疗中的应用现状与展望[J]. 国际外科学杂志, 2025, 52(04): 221-225.
[48]	Wang P, Zhang D, Huang B, et al. Robotic versus laparoscopic hepatectomy: meta-analysis of propensity-score matched studies [J]. BJS Open, 2025, 9(2): zrae141.
[49]	刘世奇, 严雨楼, 金铨, 等. 机器人与腹腔镜肝切除术近期疗效的Meta分析[J]. 腹腔镜外科杂志, 2023, 28(02): 85-94.
[50]	Lin JX, Lin JP, Wang ZK, et al. Assessment of Laparoscopic Spleen-Preserving Hilar Lymphadenectomy for Advanced Proximal Gastric Cancer Without Invasion Into the Greater Curvature: A Randomized Clinical Trial [J]. JAMA Surg, 2023, 158(1): 10-18.
[51]	宋武, 汪晓峰. 腹腔镜胃癌根治术中No. 16淋巴结清扫价值及技术要点[J]. 中国实用外科杂志, 2023, 43(09): 1012-1015.
[52]	张珂诚, 陈凛. 胃癌肝转移外科治疗进展的共识与争议[J]. 中华医学杂志, 2021, 101(14): 975-978.
[53]	梁孟杰, 朱欢欢, 王行舟, 等. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/CD]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[54]	梁华元, 谢青, 孙孝文, 等. 晚期胃癌转化治疗后行手术干预的调查研究[J]. 中华消化外科杂志, 2024, 23(11): 1430-1436.
[55]	Sato S, Tanabe K, Ota H, et al. Successful management of multiple liver metastasis from gastric cancer with second conversion surgery: A case report [J]. Int J Surg Case Rep, 2023, 107: 108340.
[56]	Hirose Y, Aizawa M, Yabusaki H, et al. Prognostic Role of Preoperative Chemotherapy in Liver-Limited Metastasis from Gastric Cancer [J]. Ann Surg Oncol, 2024, 31(7): 4213-4223.
[57]	Fujitani K, Kurokawa Y, Wada R, et al. Prospective single-arm multicenter interventional study of surgical resection for liver metastasis from gastric cancer; 3-year overall and recurrence-free survival [J]. Eur J Cancer, 2024, 213: 115080.
[58]	Katsumata K, Morimoto Y, Aoyama J, et al. Conversion surgery for gastric remnant cancer with liver metastasis after nivolumab combination chemotherapy achieving pathological complete response: a case report and literature review [J]. Surg Case Rep, 2024, 10(1): 107.
[59]	Jun C, Yamauchi S, Yube Y, et al. Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer [J]. Surg Case Rep, 2023, 9(1): 86.
[60]	高磊, 俞阳, 李晓梅, 等. 化疗与免疫检查点抑制剂联用对肿瘤的作用研究进展[J]. 解放军医学杂志, 2022, 47(11): 1152-1158.
[61]	袁泽南, 蔡建业, 李海波, 等. 介入联合免疫及抗血管生成靶向一线转化治疗晚期肝癌的临床疗效[J]. 中华消化外科杂志, 2022, 21(S1): 15-19.
[62]	车生富, 高众提, 庆会国, 等. 真实世界免疫抑制剂联合不同化疗方案新辅助治疗进展期胃癌的研究[J]. 中国肿瘤临床, 2025, 52(09): 447-453.
[63]	中华医学会外科学分会腹腔镜与内镜外科学组, 中国抗癌协会胃癌专业委员会, 中国抗癌协会腔镜与机器人外科分会, 等. 精准外科胃癌转化治疗专家共识（2025版）[J]. 中华消化外科杂志, 2025, 24(03): 281-292.
[64]	胡祥, 范义川, 张驰. 吲哚菁绿引导示踪下机器人胃癌手术的应用现状及发展前景[J]. 中华消化外科杂志, 2025, 24(03): 310-316.

Please choose a citation manager

Content to export